The company said its EscharEx treatment had previously demonstrated its ability to effectively and rapidly remove damaged or ...

YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure ...

Discover the power of hydrogel: researchers at Penn State mimic tissue behaviors using special hydrogels for potential ...

A research team from the Eye & ENT Hospital of Fudan University, China, has developed a novel biocompatible nanoadhesive for ...

Exosomes, naturally occurring extracellular vesicles, have garnered increasing interest in the field of cosmetics and skincare due to their regenerative pr | Drug Discovery And Development ...

Calendula cream accelerates wound healing and enhances skin hydration due to its anti-inflammatory antimicrobial and ...

The global hyperbaric oxygen therapy (HBOT) devices market, valued at USD 3.47 billion in 2023, is poised for significant growth, reaching USD 6.86 billion by 2033 at a CAGR of 7.0%. This surge is ...

A clinical stage biopharmaceutical company developing advanced wound healing products targeting applications in the chronic wound and aesthetic procedure aftercare markets, with the potential for ...

The study, which is based on unique tissue samples from Denmark's Brain Bank located at SDU, may pave the way for new treatments that help the brain repair itself. The brain tries to repair damage ...